Skip to content

Clinical trials

Terminated Ovarian Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Terminated Country / region: France Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20093
20111
20121
20142
20163
20172
20192
20202
20216
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Nice2
Novartis Pharmaceuticals2
SOTIO Biotech AG2
Seagen Inc.2
ARCAGY/ GINECO GROUP1
Amgen1
Aravive, Inc.1
Assistance Publique - Hôpitaux de Paris1
Centre Hospitalier Metropole Savoie1
Centre Oscar Lambret1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms29
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Fallopian Tube Neoplasms3
Melanoma3
Recurrence3
Stomach Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Hepatocellular2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.